Invasive and Non-invasive Electrical Pericranial Nerve Stimulation for the Treatment of Chronic Primary Headaches

[en] Chronic primary headaches are widespread disorders which cause significant quality of life and socioprofessional impairment. Available pharmacological treatments have often a limited efficacy and/or can generate unbearable side effects. Electrical nerve stimulation is a well known non-destructive method of pain modulation which has been recently applied to headache management. In this review, we summarise recent advances in invasive and non-invasive neurostimulation techniques targeting pericranial structures for the treatment of chronic primary headaches, chiefly migraine and cluster headache: occipital nerve, supraorbital nerve, vagus nerve, and sphenopalatineganglion stimulations. Invasive neurostimulation therapies have offered a new hope to drug-refractory headache sufferers but are not riskless and should be proposed only to chronic patients who failed to respond to most existing preventives. Non-invasive neurostimulation devices are user-friendly, safe and well tolerated and are thus taking an increasing place in the multidisciplinary therapeutical armamentarium of primary headaches.

Disciplines :

Neurology

Author, co-author :

D'Ostilio, Kevin ; Université de Liège > Département des sciences biomédicales et précliniques > Neuro-anatomie

MAGIS, Delphine ; Centre Hospitalier Universitaire de Liège - CHU > Service de neurologie (CHR)

Language :

English

Title :

Invasive and Non-invasive Electrical Pericranial Nerve Stimulation for the Treatment of Chronic Primary Headaches

Publication date :

September 2016

Journal title :

Current Pain and Headache Reports

ISSN :

1531-3433

eISSN :

1534-3081

Publisher :

Current Science, United States

Volume :

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 28 September 2016

Statistics

Number of views

56 (3 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.
Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton RB, Scher AI, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193–210.
Grazzi L, Usai S, Bussone G. Chronic headaches: pharmacological and non-pharmacological treatment. Neurol Sci. 2007;28:134–7.
Blumenfeld AM, Bloudek LM, Becker WJ, Buse DC, Varon SF, Maglinte GA, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II). Headache. 2013;53:644–55.
Stewart WF, Wood GC, Manack A, Varon SF, Buse DC, Lipton RB. Employment and work impact of chronic migraine and episodic migraine. J Occup Environ Med. 2010;52:8–14.
Zebenholzer K, Andree C, Lechner A, Broessner G, Lampl C, Luthringshausen G, et al. Prevalence, management and burden of episodic and chronic headaches—a cross-sectional multicentre study in eight Austrian headache centres. J Headache Pain. 2015;16:531.
Ambrosini A, Alessio CD, Magis D, Schoenen J. Targeting pericranial nerve branches to treat migraine: Current approaches and perspectives. 2015;35:1308–1322
Woolf C, Thompson J: Stimulation-induced analgesia: transcutaneous electrical nerve stimulation (TENS) and vibration. In: Textbook of pain. Edited by P W, R M. Livingstone: Churchill; 1994:1191–2008
Melzack R, Wall P. Pain mechanism: a new theory. Science (80). 1965;150:971–9.
Desantana JM, Da Silva LFS, De Resende MA, Sluka KA. Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats. Neuroscience. 2009;163:1233–41.
Stiller CO, Cui JG, O’Connor WT, Brodin E, Meyerson BA, Linderoth B. Release of gamma-aminobutyric acid in the dorsal horn and suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats. Neurosurgery. 1996;39:367–75.
Stiller CO, Linderoth B, O’Connor WT, Franck J, Falkenberg T, Ungerstedt U, et al. Repeated spinal cord stimulation decreases the extracellular level of gamma-aminobutyric acid in the periaqueductal gray matter of freely moving rats. Brain Res. 1995;699:231–41.
Martelletti P, Jensen RH, Antal A, Arcioni R, Brighina F, Tommaso M De, Franzini A, Fontaine D, Heiland M, Jürgens TP, et al. Neuromodulation of chronic headaches: position statement from the European Headache Federation. 2013;14:1–16. This is the first consensus paper on neuromodulation and its place in headache management.
Jasper JF, Hayek SM. Implanted occipital nerve stimulators. Pain Physician. 2008;11:187–200.
Trentman TL, Zimmerman RS, Dodick DW. Occipital nerve stimulation: technical and surgical aspects of implantation. Prog Neurol Surg. 2011;24:96–108.
Piovesan EJ, Kowacs PA, Oshinsky ML. Convergence of cervical and trigeminal sensory afferents. Curr Pain Headache Rep. 2003;7:377–83.
Goadsby PJ. Neurostimulation in primary headache syndromes. Expert Rev Neurother. 2007;7:1785–9.
Johnston MM, Jordan SE, Charles AC. Pain referral patterns of the C1 to C3 nerves: implications for headache disorders. Ann Neurol. 2013;74:145–8. This is a very interesting trial that shows neuroanatomical variations in pain referral patterns of high cervical roots between healthy subjects and subjects with primary headaches.
Ashkenazi A, Levin M. Greater occipital nerve block for migraine and other headaches: is it useful? Curr Pain Headache Rep. 2007;11:231–5.
Ambrosini A, Vandenheede M, Rossi P, Aloj F, Sauli E, Pierelli F, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain. 2005;118:92–6.
Magis D, Allena M, Bolla M, De Pasqua V, Remacle JM, Schoenen J. Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol. 2007;6:314–21. This is the first study showing the efficacy of invasive occipital nerve stimulation in chronic cluster headache treatment.
Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31:271–85. The first published RCT showing promising results of invasive occipital nerve stimulation for refractory chronic migraine management.
Matharu MS, Bartsch T, Ward N, Frackowiak RSJ, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004;127:220–30.
Magis D, Bruno M-A, Fumal A, Gérardy P-Y, Hustinx R, Laureys S, et al. Central modulation in cluster headache patients treated with occipital nerve stimulation: an FDG-PET study. BMC Neurol. 2011;11:25.
Wilbrink LA, Teernstra OPM, Haan J, van Zwet EW, Evers SMAA, Spincemaille GH, et al. Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: rationale and protocol of a randomised trial. Cephalalgia. 2013;33:1238–47.
Magis D, Gérard P, Schoenen J. Invasive occipital nerve stimulation for refractory chronic cluster headache: what evolution at long-term? Strengths and weaknesses of the method. J Headache Pain. 2016;17:8. This other open trial shows that iONS remains overall effective in most refractory cluster headache patients up to 9 years after implantation, although none of them remained totally pain-free. It also highlights most common side effects.
Magis D, Gerardy PY, Remacle JM, Schoenen J. Sustained effectiveness of occipital nerve stimulation in drug-resistant chronic cluster headache. Headache. 2011;51:1191–201.
Burns B, Watkins L, Goadsby PJ. Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet. 2007;369:1099–106. This open trials confirms long-term efficacy of iONS in refractory chronic cluster headache.
Burns B, Watkins L, Goadsby PJ. Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients. Neurology. 2009;72:341–5.
Proietti Cecchini A, Mea E, Tullo V, et al. Occipital nerve stimulation in drug-resistant chronic cluster headache. Cephalalgia. 2009;29:150 (Abstract)
Lara Lara M, Paz Solis J, Ortega-Casarubios M, PalaoTarrero A, Heredero J, Diez-Tejedor E. Occipital nerve stimulation: is peripheral approach effective in cluster headache? Cephalalgia. 2009;29:44 (Abstract)
Salom J, Lainez J. Subcutaneous occipital nerve neurostimulation treatment for refractory headaches. J Headache Pain. 2010;11:148 (Abstract)
Müller OM, Gaul C, Katsarava Z, Sure U, Diener H-C, Gasser T. Bilateral occipital nerve stimulation for the treatment of chronic cluster headache: case series and initiation of a prospective study. Fortschr Neurol Psychiatr. 2010;78:709–14.
De Quintana-Schmidt C, Casajuana-Garreta E, Molet-Teixidó J, García-Bach M, Roig C, Clavel-Laria P, et al. Stimulation of the occipital nerve in the treatment of drug-resistant cluster headache. Rev Neurol. 2010;51:19–26.
Strand NH, Trentman TL, Vargas BB, Dodick DW. Occipital nerve stimulation with the Bion® microstimulator for the treatment of medically refractory chronic cluster headache. Pain Physician. 2011;14:435–40.
Fontaine D, Christophe Sol J, Raoul S, Fabre N, Geraud G, Magne C, et al. Treatment of refractory chronic cluster headache by chronic occipital nerve stimulation. Cephalalgia. 2011;31:1101–5.
Popeney CA, Alo KM. Peripheral neurostimulation for the treatment of chronic, disabling transformed migraine. Headache. 2003;43:369–75.
Schwedt TJ, Dodick DW, Hentz J, Trentman TL, Zimmerman RS. Occipital nerve stimulation for chronic headache--long-term safety and efficacy.Cephalalgia. 2007;27(2):153–7
Lipton RB, Goadsby PJ, Cady RK, Aurora SK, Grosberg B. PRISM study: occipital nerve stimulation for treatment-refractory migraine. Cephalalgia. 2009;29:30 (Abstract)
Narouze S, Saad R, Kapural L. Occipital nerve stimulation with self-anchoring leads for the management of refractory chronic migraine. Cephalalgia. 2011;31:85 (Abstract)
Silberstein SD, Dodick DW, Saper J, Huh B, Slavin KV, Sharan A, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2012;32:1165–79. This RCT involves a high number of chronic migraine patients treated with invasive occipital nerve stimulation (iONS). Even if the primary endpoint was not achieved, the 30% responder rate was significant in the iONS arm. Thus, this points out that iONS has a place in refractory chronic migraine treatment after failure of non invasive therapies.
Dodick DW, Silberstein SD, Reed KL, Deer TR, Slavin KV, Huh B, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2014;35:344–58. This is the first long-term follow-up study of chronic migraine patients treated with iONS, involving the population of the abovementioned study (reference 38), and suggesting a sustained efficacy of iONS in these patients.
Serra G, Marchioretto F. Occipital nerve stimulation for chronic migraine: a randomized trial. Pain Physician. 2012;15:245–53.
Palmisani S, Al-Kaisy A, Arcioni R, Smith T, Negro A, Lambru G, et al. A six year retrospective review of occipital nerve stimulation practice—controversies and challenges of an emerging technique for treating refractory headache syndromes. J Headache Pain. 2013;14:67.
Chen Y-F, Bramley G, Unwin G, Hanu-Cernat D, Dretzke J, Moore D, et al. Occipital nerve stimulation for chronic migraine—a systematic review and meta-analysis. PLoS One. 2015;10:e0116786.
Narouze SN, Kapural L. Supraorbital nerve electric stimulation for the treatment of intractable chronic cluster headache: a case report. Headache. 2007;47:1100–2.
Vaisman J, Markley H, Ordia J, Deer T. The treatment of medically intractable trigeminal autonomic cephalalgia with supraorbital/supratrochlear stimulation: a retrospective case series. Neuromodulation. 2012;15:374–80.
Reed KL, Black SB, Banta CJ, Will KR. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalalgia. 2010;30:260–71.
Reed KL, Will KR, Chapman J, Richter E. Combined occipital and supraorbital neurostimulation for chronic migraine headaches: an extended case series. Cephalalgia. 2011;31:98 (Abstract)
Hann S, Sharan A. Dual occipital and supraorbital nerve stimulation for chronic migraine: a single-center experience, review of literature, and surgical considerations. Neurosurg Focus. 2013;35, E9.
Clark S, Wu C, Boorman D, Chalouhi N, Zanaty M, Oshinsky M, et al. Long-term pain reduction does not imply improved functional outcome in patients treated with combined supraorbital and occipital nerve stimulation for chronic migraine. Neuromodulation. 2016;19:507–14.
Connor DEJ, Nixon M, Nanda A, Guthikonda B. Vagal nerve stimulation for the treatment of medically refractory epilepsy: a review of the current literature. Neurosurg Focus. 2012;32, E12.
Grimm S, Bajbouj M. Efficacy of vagus nerve stimulation in the treatment of depression. Expert Rev Neurother. 2010;10:87–92.
Ricardo JA, Tongju Koh E. Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res. 1978;153:1–26.
Ruffoli R, Giorgi FS, Pizzanelli C, Murri L, Paparelli A, Fornai F. The chemical neuroanatomy of vagus nerve stimulation. J Chem Neuroanat. 2011;42:288–96.
Randich A, Ren K, Gebhart GF. Electrical stimulation of cervical vagal afferents. II. Central relays for behavioral antinociception and arterial blood pressure decreases. J Neurophysiol. 1990;64:1115–24.
Rutecki P. Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia. 1990;31:1–6.
Lyubashina OA, Sokolov AY, Panteleev SS. Vagal afferent modulation of spinal trigeminal neuronal responses to dural electrical stimulation in rats. Neuroscience. 2012;222:29–37.
Nichols JA, Nichols AR, Smirnakis SM, Engineer ND, Kilgard MP, Atzori M. Vagus nerve stimulation modulates cortical synchrony and excitability through the activation of muscarinic receptors. Neuroscience. 2011;189:207–14.
Hord ED, Evans MS, Mueed S, Adamolekun B, Naritoku DK. The effect of vagus nerve stimulation on migraines. J Pain. 2003;4:530–4.
Lenaerts ME, Oommen KJ, Couch JR, Skaggs V. Can vagus nerve stimulation help migraine? Cephalalgia. 2008;28:392–5. One of the earlier retrospective series showing that invasive vagus nerve stimulation could have some efficacy in refractory migraine.
Mauskop A. Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia. 2005;25:82–6.
Cecchini AP, Mea E, Tullo V, Curone M, Franzini A, Broggi G, et al. Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data. Neurol Sci. 2009;30:101–4.
Schytz HW, Barløse M, Guo S, Selb J, Caparso A, Jensen R, et al. Experimental activation of the sphenopalatine ganglion provokes cluster-like attacks in humans. Cephalalgia. 2013;33:831–41.
Robbins MS, Robertson CE, Kaplan E, Ailani J, Charleston L, Kuruvilla D, et al. The sphenopalatine ganglion: anatomy, pathophysiology, and therapeutic targeting in headache. Headache. 2016;56:240–58.
Ansarinia M, Rezai A, Tepper SJ, Steiner CP, Stump J, Stanton-Hicks M, et al. Electrical stimulation of sphenopalatine ganglion for acute treatment of cluster headaches: views and perspectives. Headache. 2010;50:1164–74.
Schoenen J, Jensen RH, Lantéri-Minet M, Láinez MJ A, Gaul C, Goodman AM, et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia. 2013;33:816–30. First RCT showing the efficacy of an implantable SPG microstimulator for cluster headache acute therapy.
Khan S, Schoenen J, Ashina M. Sphenopalatine ganglion neuromodulation in migraine: what is the rationale? Cephalalgia. 2014;34:382–91.
Tepper SJ, Rezai A, Narouze S, Steiner C, Mohajer P, Ansarinia M. Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation: research submission. Headache. 2009;49:983–9.
Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gérard P, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80:697–704. The first randomized controlled trial (RCT) showing the efficacy of non-invasive peripheral nerve stimulation (here supraorbital nerve) in migraine prevention.
Russo A, Tessitore A, Conte F, Marcuccio L, Giordano A, Tedeschi G. Transcutaneous supraorbital neurostimulation in “de novo” patients with migraine without aura: the first Italian experience. J Headache Pain. 2015;16:69.
Schoenen J, D’Ostilio K, Cosseddu A, Baschi R, Lisicki M, Nonis R, et al. Transcranial direct current stimulation and transcutaneous occipital nerve stimulation in chronic migraine: a pilot-comparison of therapeutic and electrophysiological effects. Neurology. 2016;86:P2.200.
Nesbitt AD, Marin JC, Tompkins E, Ruttledge MH, Goadsby PJ. Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment. Neurology. 2015;84:1249–53.
Barbanti P, Grazzi L, Egeo G, Padovan AM, Liebler E, Bussone G. Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study. J Headache Pain. 2015;16:61.
Kinfe TM, Pintea B, Muhammad S, Zaremba S, Roeske S, Simon BJ, et al. Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: a prospective observational cohort study. J Headache Pain. 2015;16:101.
Straube A, Ellrich J, Eren O, Blum B, Ruscheweyh R. Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial. J Headache Pain. 2015;16:63. This interesting recent trial demonstrates the efficacy of 1 Hz non-invasive neurostimulation of the auricular branch of the vagus nerve in chronic migraine, whereas the 25Hz stimulation provides no significant benefit.
Magis D, Sava S, D’Elia TS, Baschi R, Schoenen J. Safety and patients’ satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population. J. Headache Pain. 2013;14. A prospective registry involving more than 2000 users of non-invasive supraorbital nerve stimulation that mainly discloses the very low rate of adverse events and underlines the issue of adherence to treatment in non-responderst.
Magis D, D’Ostilio K, Thibaut A, De Pasqua V, Gerard P, Hustinx R, et al. Cerebral metabolism before and after external trigeminal nerve stimulation in episodic migraine. Cephalalgia. 2016. doi:10.1177/0333102416656118.
Chen S-P, Ay I, Lopes de Morais A, Qin T, Zheng Y, Sadhegian H, et al. Vagus nerve stimulation inhibits cortical spreading depression. Pain. 2015;157:1.
Gaul C, Diener H-C, Silver N, Magis D, Reuter U, Andersson A, et al. Non-invasive vagus nerve stimulation for prevention and acute treatment of chronic cluster headache (PREVA): a randomised controlled study. Cephalalgia. 2016;36:534–46. This study, though not sham-controlled, is the first to demonstrate the efficacy of a non-invasive neurostimulation technique (vagus nerve stimulation - nVNS) in chronic cluster headache. Moreover, it is the largest clinical trial ever published in chronic cluster headache prevention, a rare condition, with a population of nearly 100 patients.
Goadsby P, Grosberg B, Mauskop A, Cady R, Simmons K. Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia. 2014;34:986–93. This study shows the efficacy of non-invasive vagus nerve stimulation (nVNS) in the treatment of the migraine attack. Though modest, these results open the way for the possible use of transcutaneous vagus nerve stimulation in patients who have contraindications or do not respond to acute antimigraine drugs.